Edith L. Pfister
Sanofi (United States)(US)
Publications by Year
Research Areas
Genetic Neurodegenerative Diseases, RNA Research and Splicing, CRISPR and Genetic Engineering, Muscle Physiology and Disorders, Mitochondrial Function and Pathology
Most-Cited Works
- → Five siRNAs Targeting Three SNPs May Provide Therapy for Three-Quarters of Huntington's Disease Patients(2009)248 cited
- → HTT-lowering reverses Huntington’s disease immune dysfunction caused by NFκB pathway dysregulation(2014)184 cited
- → Epidemiologic Study of Abuse of Analgesics Containing Phenacetin(1983)138 cited
- → Artificial miRNAs Reduce Human Mutant Huntingtin Throughout the Striatum in a Transgenic Sheep Model of Huntington's Disease(2017)86 cited
- → Chemical engineering of therapeutic siRNAs for allele-specific gene silencing in Huntington’s disease models(2022)46 cited
- → Alterations in mRNA 3′ UTR Isoform Abundance Accompany Gene Expression Changes in Human Huntington’s Disease Brains(2017)46 cited
- → Cellular Analysis of Silencing the Huntington’s Disease Gene Using AAV9 Mediated Delivery of Artificial Micro RNA into the Striatum of Q140/Q140 Mice(2016)35 cited
- → Safe and Efficient Silencing with a Pol II, but Not a Pol lII, Promoter Expressing an Artificial miRNA Targeting Human Huntingtin(2017)28 cited
- → Allele-Selective Suppression of Mutant Huntingtin in Primary Human Blood Cells(2017)26 cited
- → Huntington's disease: Silencing a brutal killer(2009)23 cited